Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.

Cecílio P, Pérez-Cabezas B, Fernández L, Moreno J, Carrillo E, Requena JM, Fichera E, Reed SG, Coler RN, Kamhawi S, Oliveira F, Valenzuela JG, Gradoni L, Glueck R, Gupta G, Cordeiro-da-Silva A

Open source

DOI: 10.1371/journal.pntd.0005951
Published: 2017 Nov
Container: PLoS neglected tropical diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pntd.0005951,
  title = {Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.},
  author = {Cecílio P and Pérez-Cabezas B and Fernández L and Moreno J and Carrillo E and Requena JM and Fichera E and Reed SG and Coler RN and Kamhawi S and Oliveira F and Valenzuela JG and Gradoni L and Glueck R and Gupta G and Cordeiro-da-Silva A},
  year = {2017},
  journal = {PLoS neglected tropical diseases},
  doi = {10.1371/journal.pntd.0005951},
  url = {https://doi.org/10.1371/journal.pntd.0005951}
}

RIS

TY  - JOUR
TI  - Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.
AU  - Cecílio P
AU  - Pérez-Cabezas B
AU  - Fernández L
AU  - Moreno J
AU  - Carrillo E
AU  - Requena JM
AU  - Fichera E
AU  - Reed SG
AU  - Coler RN
AU  - Kamhawi S
AU  - Oliveira F
AU  - Valenzuela JG
AU  - Gradoni L
AU  - Glueck R
AU  - Gupta G
AU  - Cordeiro-da-Silva A
PY  - 2017
JO  - PLoS neglected tropical diseases
DO  - 10.1371/journal.pntd.0005951
UR  - https://doi.org/10.1371/journal.pntd.0005951
ER  -

APA

P, C., B, P., L, F., J, M., E, C., JM, R., E, F., SG, R., RN, C., S, K., F, O., JG, V., L, G., R, G., G, G., & A, C. (2017). Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.. PLoS neglected tropical diseases. https://doi.org/10.1371/journal.pntd.0005951

Source records

pubmed · retrieved 2026-09-26T16:22:32.998Z